BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

120 hedge funds and large institutions have $439M invested in BioCryst Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
+5
Holders Change %
+4.35%
% of All Funds
3%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
22
Increased
42
Reduced
28
Closed
17
Calls
$1.11M
Puts
$4.83M
Net Calls
-$3.73M
Net Calls Change
-$7.98M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
$23.8M
2
BBA
Baker Bros. Advisors
New York
$73.3M
3
RCM
RA Capital Management
Massachusetts
$36.6M
4
GPP
Great Point Partners
Connecticut
$8.58M
5
DM
Deerfield Management
New York
$26.1M

Top Sellers

1
State Street
State Street
Massachusetts
$15.5M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
$7.82M
3
Goldman Sachs
Goldman Sachs
New York
$1.89M
4
UONDDL
University of Notre Dame du Lac
Indiana
$0
5
PC
Paulson & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$73.3M +$11.9M +2,280,388 +19%
RCM
2
RA Capital Management
Massachusetts
$36.6M +$9.55M +1,822,450 +35%
BlackRock
3
BlackRock
New York
$34.7M +$1.9M +362,803 +6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$31.5M -$3.84K -732 -0%
DM
5
Deerfield Management
New York
$26.1M +$7.74M +1,476,249 +42%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$23.8M +$23.8M +4,534,727 New
Millennium Management
7
Millennium Management
New York
$19.7M +$1.84M +350,301 +10%
RI
8
RTW Investments
New York
$17.4M -$48.5K -9,253 -0.3%
VMI
9
VHCP Management II
New York
$16.6M +$3.62M +690,290 +28%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$16.4M – – –
Jennison Associates
11
Jennison Associates
New York
$16.1M +$5.22M +995,643 +48%
State Street
12
State Street
Massachusetts
$15.5M -$4.93M -941,428 -24%
ACA
13
Avoro Capital Advisors
New York
$9.32M -$917K -175,000 -9%
GPP
14
Great Point Partners
Connecticut
$8.58M +$8.58M +1,637,332 New
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$7.82M -$3.12M -595,690 -29%
Citadel Advisors
16
Citadel Advisors
Florida
$7.31M +$6.5M +1,239,689 +795%
DCM
17
DAFNA Capital Management
California
$6.25M +$3.16M +602,100 +102%
Northern Trust
18
Northern Trust
Illinois
$5.3M +$21.1K +4,035 +0.4%
ACP
19
Acuta Capital Partners
California
$5.22M +$4.34M +827,615 +491%
Invesco
20
Invesco
Georgia
$5.01M -$388 -74 -0%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.92M +$488K +93,166 +14%
AG
22
Artal Group
Luxembourg
$3.41M -$1.05M -200,000 -24%
TCIM
23
TIAA CREF Investment Management
New York
$2.63M +$173K +33,048 +7%
GTC
24
Ghost Tree Capital
New York
$2.62M -$917K -175,000 -26%
Alyeska Investment Group
25
Alyeska Investment Group
Illinois
$2.36M +$2.36M +450,000 New
1
2 3 4 5